---
title: "Sports Medicine Physician Guide To Adipose Banking In 2026 - Save My Fat"
description: "Sports medicine practices see active patients with long time horizons, which makes banking a plausible preservation offering, but banking is..."
url: "https://savemyfat.com/sports-medicine-physician-guide-to-adipose-banking/"
---

# Sports Medicine Physician Guide to Adipose Banking in 2026

#### Table of Contents

- [Oscar Tellez](https://savemyfat.com/author/oscartellez/)
- [July 29, 2026](https://savemyfat.com/2026/07/29/)
- 10:00 am

![Sports medicine physician guide to adipose banking in 2026](https://savemyfat.com/wp-content/uploads/2026/06/July-29-1024x1024.png)Sports medicine physician guide to adipose banking in 2026 2

Sports medicine physicians work with active patients who have long health horizons and an interest in musculoskeletal care, which makes adipose banking a topic worth understanding accurately. With Wyoming’s law now in effect alongside Florida’s, the state landscape has shifted, while the musculoskeletal evidence remains more sobering than marketing suggests. This guide covers the law, the evidence as it actually stands, athlete-specific considerations, and the operational details.

**TLDR:**Sports medicine practices see active patients with long time horizons, which makes banking a plausible preservation offering, but banking is preservation rather than a treatment or performance enhancement. Florida’s law names orthopedics and pain management, and Wyoming’s law, effective July 1, 2026, covers autologous mesenchymal stem cell therapy, though both govern administering therapy, not banking. The musculoskeletal evidence is sobering: a major autologous adipose knee osteoarthritis trial did not meet its endpoints, and microfragmented adipose evidence remains preliminary. No adipose-derived product is FDA-approved for any musculoskeletal indication. Banking preserves a patient’s own tissue under 21 CFR Part 1271; it is not a treatment and guarantees no eligibility, access, or clinical benefit.

**Important Disclaimer:** Save My Fat does not provide FDA-approved treatments or cures for any disease, including orthopedic or musculoskeletal conditions. No adipose-derived stem cell product currently has FDA approval for any musculoskeletal indication. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.

---

Athletes and active patients are often motivated to hear about anything framed as regenerative, which makes an honest read essential. The sections below separate the preservation decision from the investigational evidence and the state-law scope.

## Why Sports Medicine Is a Natural Banking Specialty

Sports medicine attracts patients who are active, health-conscious, and often younger, with long time horizons and an interest in musculoskeletal health. Those characteristics make banking a plausible preservation consideration, because the preservation logic some patients cite, that cells are younger now than later, aligns with a younger active population. Sports medicine practices also frequently operate on a cash-pay basis for certain services, which fits an elective preservation offering.

The honest version of this fit is narrow. A motivated, active patient panel is a plausible audience for a preservation service, but that does not make banking a treatment for any injury or condition, and it is never a performance enhancement. Sports medicine physicians, who are often not surgeons, can offer banking as preservation while keeping the boundary clear. The orthopedic-focused overview of [adipose banking rules](/adipose-banking-for-orthopedic-physicians-rules/) covers related considerations.

## State Law Scope for Sports Medicine Physicians: FL and WY

Two states are particularly relevant to sports medicine. Florida Statutes Section 458.3245, effective July 1, 2025, permits physicians to administer non-FDA-approved stem cell therapy within orthopedics, wound care, and pain management, two of which are squarely within sports medicine. However, the statute requires accredited-facility sourcing, and credible legal analyses read it as excluding adipose-derived cells as a permitted therapy source, which counsel should confirm. Wyoming’s Stem Cell Freedom Act, codified at W.S. 33-26-202(b) and effective July 1, 2026, covers autologous mesenchymal stem cell therapy, including adipose-derived cells, with a physician licensing shield.

The table compares the two.

Feature Florida Section 458.3245 Wyoming W.S. 33-26-202(b) (SF 48)

Effective July 1, 2025 July 1, 2026

Scope Orthopedics, wound care, pain management Autologous mesenchymal stem cells

Adipose as a therapy source Credible readings exclude adipose Includes autologous adipose

What it governs Administering non-FDA-approved therapy Administering non-FDA-approved therapy

Banking Not addressed; separate activity Not addressed; separate activity

The essential point is that both laws govern administering therapy, not banking. The [SB 1768 checklist](/florida-sb-1768-the-complete-physician-checklist/) covers Florida’s provider obligations, and banking remains a separate preservation activity in both states.

## The Musculoskeletal Pipeline: What the Evidence Actually Shows

The musculoskeletal evidence is where honesty matters most, because it is more sobering than marketing suggests. A significant Phase 2b trial of autologous adipose-derived cells in knee osteoarthritis, registered as [NCT02838069](https://clinicaltrials.gov/study/NCT02838069), did not meet its primary or secondary endpoints, a result that must be read as negative rather than promising. That outcome is important context for any sports medicine physician evaluating adipose-derived approaches for musculoskeletal conditions.

Microfragmented adipose tissue, often discussed in this space, also warrants a measured read. The evidence for microfragmented adipose injections remains preliminary and mixed rather than conclusive, and the overview of [microfragmented adipose evidence](/mfat-injections-what-they-are-what-evidence-shows/) summarizes what the research does and does not show. Two cautions follow: microfragmented adipose injection is an investigational same-day procedure distinct from banking, and no adipose-derived product is FDA-approved for any musculoskeletal indication. The broader [active clinical trials](/active-clinical-trials-in-adipose-derived-mscs-2026/) overview shows where musculoskeletal research stands. None of this evidence supports presenting banking as a musculoskeletal treatment.

## Athlete-Specific Banking Considerations

Athletes present specific considerations, mostly favorable to the preservation logic but requiring careful framing. Athletes are often younger with long time horizons, which fits the rationale that tissue banked earlier reflects a relatively earlier biological state. An athlete already undergoing an elective procedure may also find harvest timing convenient.

The crucial boundary is that banking is not a performance enhancement, not an injury treatment, and not a recovery aid. An athlete who banks is making a preservation decision, not gaining a competitive or therapeutic advantage, and the conversation must make that explicit. Presenting banking to athletes as anything other than preservation would be both inaccurate and a disservice, because no adipose-derived product is FDA-approved for any musculoskeletal or performance indication.

## Harvest Integration in a Sports Medicine Practice

For a sports medicine practice, a banking collection is typically coordinated through an appropriate procedural workflow, and it can sometimes be aligned with a planned outpatient procedure if a patient elects banking. The harvest for banking is a collection step whose purpose is preservation, handled under proper conditions and documented carefully.

The provider-facing overview of [the harvest procedure](/the-harvest-procedure-step-by-step-for-providers/) outlines collection, handling, and transfer. The practical requirements are a suitable procedural setting, sterile technique, documented chain-of-custody, and accurate records, with the tissue transferred to the processing and storage partner. The collection is distinct from administering any therapy, and a sports medicine practice should keep that boundary explicit.

## Patient Conversation and Documentation

The patient conversation in a sports medicine practice should be candid, because active patients are often eager. A physician should explain that banking is preservation, that the musculoskeletal evidence for adipose-derived approaches is limited and includes a negative knee osteoarthritis trial, and that no adipose-derived product is FDA-approved for any musculoskeletal indication. Honest framing protects both the athlete and the practice.

Documentation should reflect this. Banking requires separate, specific informed consent that disclaims treatment and any guarantee of benefit, and records should note that banking was presented as preservation rather than as a musculoskeletal or performance intervention. The service operates under [21 CFR Part 1271](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-L/part-1271), and banking records should be kept separate from any clinical care records.

## Physician Action Checklist

A condensed action list for a sports medicine practice:

- Confirm with counsel how Florida Section 458.3245 and Wyoming W.S. 33-26-202(b) apply, including that banking is distinct from administering therapy and that Florida’s adipose permitted-source question is resolved.
- Communicate the musculoskeletal evidence honestly, including the negative knee osteoarthritis trial and the preliminary nature of microfragmented adipose evidence.
- Frame banking as preservation, never as an injury treatment, recovery aid, or performance enhancement.
- Obtain separate, specific banking consent that disclaims treatment and any guarantee of benefit.
- Coordinate harvest through an appropriate procedural workflow with documented chain-of-custody.
- Confirm the banking partner operates under 21 CFR Part 1271 and retain documentation of its regulatory status.

## Frequently Asked Questions

### Does Florida or Wyoming law authorize adipose banking for sports medicine?

No. Florida Section 458.3245 names orthopedics and pain management but governs administering therapy, and credible readings exclude adipose as a permitted source. Wyoming W.S. 33-26-202(b) covers administering autologous therapy. Neither addresses banking, which is a separate preservation activity.

### What does the evidence show for adipose-derived musculoskeletal treatments?

It is limited. A Phase 2b autologous adipose trial in knee osteoarthritis did not meet its endpoints, and microfragmented adipose evidence is preliminary and mixed. No adipose-derived product is FDA-approved for any musculoskeletal indication.

### Does banking help athletes recover or perform better?

No. Banking is preservation of a patient’s own tissue for potential future use. It is not an injury treatment, a recovery aid, or a performance enhancement, and no adipose-derived product is FDA-approved for any musculoskeletal or performance indication.

### Is microfragmented adipose injection the same as banking?

No. Microfragmented adipose injection is an investigational same-day procedure, while banking is collection and preservation of tissue for potential future use. They are different activities, and banking does not provide any injection therapy.

### How is adipose tissue banking regulated?

Banked adipose tissue is handled under 21 CFR Part 1271, the federal framework governing screening, processing, and storage of human cells and tissues.

## Key Takeaways

For sports medicine physicians, banking fits some practices as preservation, but the evidence and the law both require honesty. Florida’s law names orthopedics and pain management, and Wyoming’s law, codified at W.S. 33-26-202(b) and effective July 1, 2026, covers autologous mesenchymal stem cell therapy, though both govern administering therapy rather than banking. The musculoskeletal evidence is sobering, including a negative Phase 2b autologous adipose knee osteoarthritis trial and preliminary microfragmented adipose data, and no adipose-derived product is FDA-approved for any musculoskeletal indication. Banking is never an injury treatment, recovery aid, or performance enhancement, and any harvest requires separate consent, documented chain-of-custody, and a partner operating under 21 CFR Part 1271. Above all, banking adipose tissue is a preservation service for potential future use; it is not a treatment, and it does not guarantee eligibility, access, or clinical benefit.

Save My Fat operates as a tissue preservation service, not a medical practice or treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, and Nevada governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.

Sports medicine practices evaluating whether to add a preservation service can review the service model and [contact the team](/contact-us/) to discuss integration and documentation requirements.

---

*Save My Fat partners with a U.S.-based tissue bank for laboratory processing and storage.*

*This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review including sports medicine input is required before publication. Please consult your sports medicine physician before making any decisions about treatment or research participation.*

**About the author:** Oscar Tellez is the founder and CEO of Save My Fat. He holds a Bachelor of Science in Exercise Science and Health Promotion from Florida Atlantic University. He has spent more than a decade in the regenerative medicine industry across product distribution, laboratory and vendor relationships, and provider training. He is not a licensed clinician, and this article is educational, not medical advice.

**Related guide:** [the physician resource center](https://savemyfat.com/physician-resource-center/).

[PrevPreviousHow Save My Fat Works With Your Physician: A Patient Guide](https://savemyfat.com/how-save-my-fat-works-with-your-physician-your-guide/)

[NextAdipose Banking Pricing: What You Actually Pay ForNext](https://savemyfat.com/adipose-banking-pricing-what-you-actually-pay-for/)

Providers

### [Urologist Guide to Adipose Banking and the Erectile Dysfunction Research Landscape](https://savemyfat.com/erectile-dysfunction-research-adipose-banking/)

 [Read More »](https://savemyfat.com/erectile-dysfunction-research-adipose-banking/)

Oscar Tellez 08/23/2026 10:00 AM

Providers

### [Dermatologist Guide to Adipose Banking: What the Research Landscape Looks Like in 2026](https://savemyfat.com/dermatologist-adipose-banking-guide/)

 [Read More »](https://savemyfat.com/dermatologist-adipose-banking-guide/)

Oscar Tellez 08/22/2026 10:00 AM

Clinical Trials

### [What Happens If a Clinical Trial for Adipose-Derived Cells Is Terminated Early](https://savemyfat.com/terminated-clinical-trial-what-it-means/)

 [Read More »](https://savemyfat.com/terminated-clinical-trial-what-it-means/)

Oscar Tellez 08/21/2026 10:00 AM

Clinical Trials

### [The Multiple System Atrophy Trial Landscape Beyond Mayo Clinic: What Else Is Being Studied](https://savemyfat.com/multiple-system-atrophy-clinical-trials-2026/)

 [Read More »](https://savemyfat.com/multiple-system-atrophy-clinical-trials-2026/)

Oscar Tellez 08/20/2026 10:00 AM

Regulation

### [Ryoncil in 2026: What Changed Since the First FDA-Approved MSC Therapy](https://savemyfat.com/ryoncil-2026-update-first-approved-msc-therapy/)

 [Read More »](https://savemyfat.com/ryoncil-2026-update-first-approved-msc-therapy/)

Oscar Tellez 08/19/2026 10:00 AM

Clinical Trials

### [NCT06002841 Explained: What This Registered Clinical Trial Is Studying](https://savemyfat.com/extracellular-vesicle-trial-nct06002841/)

 [Read More »](https://savemyfat.com/extracellular-vesicle-trial-nct06002841/)

Oscar Tellez 08/18/2026 10:00 AM

```json
[{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"#article","headline":"Sports Medicine Physician Guide To Adipose Banking In 2026 - Save My Fat","name":"Sports Medicine Physician Guide To Adipose Banking In 2026 - Save My Fat","datePublished":"2026-07-29T10:00:00-04:00","dateModified":"2026-08-05T14:45:37-04:00","description":"Sports medicine practices see active patients with long time horizons, which makes banking a plausible preservation offering, but banking is...","inLanguage":"en-US","image":"https:\/\/savemyfat.com\/wp-content\/uploads\/2026\/06\/July-29.png","isPartOf":{"@id":"#webpage"},"author":{"@type":"Person","@id":"https:\/\/savemyfat.com\/oscar-tellez\/#person","name":"Oscar Tellez","jobTitle":"Founder","url":"https:\/\/savemyfat.com\/oscar-tellez"},"publisher":{"@type":"Organization","@id":"https:\/\/savemyfat.com\/#organization","name":"SaveMyFat","url":"https:\/\/savemyfat.com"},"articleSection":"Adipose Banking, Providers, Stem Cells"},{"@type":"Organization","@id":"https:\/\/savemyfat.com\/#organization","name":"Save My Fat","sameAs":["https:\/\/www.facebook.com\/savemyfat\/","https:\/\/www.linkedin.com\/company\/save-my-fat","https:\/\/www.instagram.com\/savemyfat\/","https:\/\/search.sunbiz.org\/Inquiry\/CorporationSearch\/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=SAVEMYFAT%20L260000005000&aggregateId=flal-l26000000500-32d6bf22-6788-4c6f-a062-b944408d7cda&searchTerm=SAVE%20MY%20LLC&listNameOrder=SAVEMY%20L250004108200"],"logo":{"@type":"ImageObject","@id":"https:\/\/savemyfat.com\/#logo","url":"https:\/\/savemyfat.com\/wp-content\/uploads\/2025\/12\/Blk-Txt-Blk-BG-SMF.svg","contentUrl":"https:\/\/savemyfat.com\/wp-content\/uploads\/2025\/12\/Blk-Txt-Blk-BG-SMF.svg","caption":"Save My Fat","inLanguage":"en-US","width":"500","height":"500"}},{"@type":"WebSite","@id":"https:\/\/savemyfat.com\/#website","url":"https:\/\/savemyfat.com","name":"Save My Fat","alternateName":"https:\/\/savemyfat.com","publisher":{"@id":"https:\/\/savemyfat.com\/#organization"},"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/savemyfat.com\/wp-content\/uploads\/2026\/06\/July-29.png","url":"https:\/\/savemyfat.com\/wp-content\/uploads\/2026\/06\/July-29.png","width":"1050","height":"1050","caption":"Sports Medicine Physician Guide to Adipose Banking in 2026","inLanguage":"en-US"},{"@type":"BreadcrumbList","@id":"https:\/\/savemyfat.com\/sports-medicine-physician-guide-to-adipose-banking\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":"1","item":{"@id":"https:\/\/savemyfat.com","name":"Home"}},{"@type":"ListItem","position":"2","item":{"@id":"https:\/\/savemyfat.com\/our-blog\/","name":"Our Blog"}},{"@type":"ListItem","position":"3","item":{"@id":"https:\/\/savemyfat.com\/category\/adipose-banking\/","name":"Adipose Banking"}},{"@type":"ListItem","position":"4","item":{"@id":"https:\/\/savemyfat.com\/sports-medicine-physician-guide-to-adipose-banking\/","name":"Sports Medicine Physician Guide to Adipose Banking in 2026"}}]},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/savemyfat.com\/sports-medicine-physician-guide-to-adipose-banking\/#webpage","url":"https:\/\/savemyfat.com\/sports-medicine-physician-guide-to-adipose-banking\/","name":"Sports Medicine Physician Guide To Adipose Banking In 2026 - Save My Fat","datePublished":"2026-07-29T10:00:00-04:00","dateModified":"2026-08-05T14:45:37-04:00","isPartOf":{"@id":"https:\/\/savemyfat.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/savemyfat.com\/wp-content\/uploads\/2026\/06\/July-29.png"},"inLanguage":"en-US","breadcrumb":{"@id":"https:\/\/savemyfat.com\/sports-medicine-physician-guide-to-adipose-banking\/#breadcrumb"},"mainEntity":[{"@type":"Question","name":"What is adipose tissue banking?","acceptedAnswer":{"@type":"Answer","text":"Adipose tissue banking is the process of collecting, processing, and cryopreserving your own body fat for potential future use in FDA-regulated clinical research, Expanded Access programs, or approved therapies. It is a preservation service, not a treatment."}},{"@type":"Question","name":"Is adipose tissue banking FDA-approved?","acceptedAnswer":{"@type":"Answer","text":"Tissue banking as a preservation service is not a product requiring FDA approval. However, any future medical use of stored tissue must comply with FDA regulations at that time. Products derived from adipose tissue that undergo more than minimal manipulation typically require IND applications and a Biologics License Application before legal marketing."}}]}]},{"@context":"https:\/\/schema.org","@graph":[{"@type":"Person","@id":"https:\/\/savemyfat.com\/oscar-tellez\/#person","name":"Oscar Tellez","jobTitle":"Founder","description":"Oscar Tellez is the Founder of SaveMyFat, a national adipose tissue banking company that helps individuals preserve their own fat-derived stem cells for potential future use in FDA-regulated research pathways.","url":"https:\/\/savemyfat.com\/oscar-tellez","email":"info@savemyfat.com","image":{"@type":"ImageObject","url":"https:\/\/savemyfat.com\/wp-content\/uploads\/2026\/05\/Oscar-Headshot-Rounded-1.png","width":"200","height":"200"},"worksFor":{"@type":"Organization","@id":"https:\/\/savemyfat.com\/#organization","name":"SaveMyFat","url":"https:\/\/savemyfat.com"},"knowsAbout":["Adipose Tissue Banking","Stem Cell Cryopreservation","Regenerative Medicine","Fat-Derived Stem Cells","Expanded Access Pathways"],"sameAs":["https:\/\/savemyfat.com\/oscar-tellez","https:\/\/www.linkedin.com\/in\/o-tellez\/","https:\/\/www.facebook.com\/savemyfat\/","https:\/\/www.instagram.com\/savemyfat\/"]},{"@type":"Article","headline":"Sports Medicine Physician Guide to Adipose Banking in 2026","url":"https:\/\/savemyfat.com\/sports-medicine-physician-guide-to-adipose-banking\/","datePublished":"2026-07-29T10:00:00-04:00","dateModified":"2026-08-05T14:45:37-04:00","description":"Sports medicine practices see active patients with long time horizons, which makes banking a plausible preservation offering, but banking is preservation rather than a treatment or performance enhancement. Florida's law names orthopedics and pain management, and Wyoming's law, effective July 1, 2026, covers autologous mesenchymal stem cell therapy, though both govern administering therapy, not banking. The musculoskeletal evidence is sobering: a major autologous adipose knee osteoarthritis trial did not meet its endpoints, and microfragmented adipose evidence remains preliminary. No adipose...","abstract":"Sports medicine practices see active patients with long time horizons, which makes banking a plausible preservation offering, but banking is preservation rather than a treatment or performance enhancement. Florida's law names orthopedics and pain management, and Wyoming's law, effective July 1, 2026, covers autologous mesenchymal stem cell therapy, though both govern administering therapy, not banking. The musculoskeletal evidence is sobering: a major autologous adipose knee osteoarthritis trial did not meet its endpoints, and microfragmented adipose evidence remains preliminary. No adipose...","author":{"@type":"Person","@id":"https:\/\/savemyfat.com\/oscar-tellez\/#person","name":"Oscar Tellez","jobTitle":"Founder","url":"https:\/\/savemyfat.com\/oscar-tellez"},"publisher":{"@type":"Organization","@id":"https:\/\/savemyfat.com\/#organization","name":"SaveMyFat","url":"https:\/\/savemyfat.com"},"speakable":{"@type":"SpeakableSpecification","cssSelector":["#tldr-summary"],"xpath":["\/\/*[@id=\"tldr-summary\"]"]}}]}]
```